Skip to main content

Are you Dr. Olin?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
    You already have 23 invites waiting!
  • Read the latest clinical news, personalized to your specialty.

Claim this profile

Not you? Find your profile

  • Office

    63 Eddie Dowling Hwy
    Suite 7
    North Smithfield, RI 02896
    Phone+1 401-765-1213
    Fax+1 401-765-7995

Summary

  • Dr. Michael Olin, MD is a neurosurgeon in North Smithfield, Rhode Island. He is currently licensed to practice medicine in Rhode Island, Florida, and Vermont. He is affiliated with Landmark Medical Center, Miriam Hospital, and Roger Williams Medical Center.

Education & Training

  • University of Connecticut School of Medicine
    University of Connecticut School of MedicineResidency, Neurological Surgery, 1982 - 1983
  • University of Vermont Medical Center
    University of Vermont Medical CenterResidency, Neurological Surgery, 1979 - 1981
  • Brown University/Rhode Island Hospital-Lifespan
    Brown University/Rhode Island Hospital-LifespanResidency, Surgery, 1976 - 1977
  • Brown University
    Brown UniversityInternship, Internal Medicine, 1975 - 1976
  • Universidad Autonoma de Guadalajara
    Universidad Autonoma de GuadalajaraClass of 1974

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2013 - 2027
  • RI State Medical License
    RI State Medical License 1978 - 2020
  • VT State Medical License
    VT State Medical License 1979 - 1984
  • American Board of Neurological Surgery Neurological Surgery

Awards, Honors, & Recognition

  • Fellow (FACS) American College of Surgeons

Publications & Presentations

PubMed

Press Mentions

  • Unique Glioblastoma Treatment Sees Encouraging Early Results During Phase 1 Clinical Trials
    Unique Glioblastoma Treatment Sees Encouraging Early Results During Phase 1 Clinical TrialsNovember 17th, 2021
  • WhyWeVax™ Announces the Creation of a Scientific Advisory Board and Six New Members
    WhyWeVax™ Announces the Creation of a Scientific Advisory Board and Six New MembersSeptember 28th, 2020
  • Why We Vaccinate Announces Coalition Formation and Board Members
    Why We Vaccinate Announces Coalition Formation and Board MembersSeptember 23rd, 2019

Professional Memberships